An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan (Q84305974)
Jump to navigation
Jump to search
scientific article published on 01 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan |
scientific article published on 01 June 2011 |
Statements
An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study (English)
Hisashi Yamanaka
Naoyuki Kamatani
Shin Fujimori
Toshikazu Hada
Tatsuo Hosoya
Kenjiro Kohri
Toshitaka Nakamura
Takanori Ueda
Tetsuya Yamamoto